Literature DB >> 30052722

Assessing Individual and Disseminated Effects in Network-Randomized Studies.

Ashley L Buchanan1, Sten H Vermund2, Samuel R Friedman3, Donna Spiegelman4.   

Abstract

Implementation trials often involve clustering via risk networks, where only some participants directly receive the intervention. The individual effect is that among directly treated persons beyond being in an intervention network; the disseminated effect is that among persons engaged with those directly treated. In this article, we employ a causal inference framework and discuss assumptions and estimators for individual and disseminated effects and apply them to the HIV Prevention Trials Network 037 Study. HIV Prevention Trials Network 037 was a phase III, network-level, randomized controlled human immunodeficiency virus (HIV) prevention trial conducted in the United States and Thailand from 2002 to 2006 that recruited injection drug users, who were assigned to either an intervention group or a control group, and their risk network members, who received no direct intervention. Combining individual and disseminated effects, we observed a 35% composite rate reduction in the adjusted model (risk ratio = 0.65, 95% confidence interval: 0.47, 0.90). Methodology is now available for estimating the full set of these effects, enhancing knowledge gained from network-randomized trials. Although the overall effect gains validity from network randomization, we show that it will generally be less than the composite effect. Additionally, if only index participants benefit from the intervention, as the network size increases, the overall effect tends toward the null-an unfortunate and misleading conclusion.

Entities:  

Mesh:

Year:  2018        PMID: 30052722      PMCID: PMC6211234          DOI: 10.1093/aje/kwy149

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  25 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Negative controls: a tool for detecting confounding and bias in observational studies.

Authors:  Marc Lipsitch; Eric Tchetgen Tchetgen; Ted Cohen
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

3.  Prevalence proportion ratios: estimation and hypothesis testing.

Authors:  T Skov; J Deddens; M R Petersen; L Endahl
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

4.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

Review 5.  Combination HIV prevention: significance, challenges, and opportunities.

Authors:  Ann E Kurth; Connie Celum; Jared M Baeten; Sten H Vermund; Judith N Wasserheit
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

6.  The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA.

Authors:  Carl A Latkin; Deborah Donnell; David Metzger; Susan Sherman; Apinun Aramrattna; Annet Davis-Vogel; Vu Minh Quan; Sharavi Gandham; Tasanai Vongchak; Tom Perdue; David D Celentano
Journal:  Soc Sci Med       Date:  2008-12-13       Impact factor: 4.634

7.  Large sample randomization inference of causal effects in the presence of interference.

Authors:  Lan Liu; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2014-01-01       Impact factor: 5.033

8.  Group sex events and HIV/STI risk in an urban network.

Authors:  Samuel R Friedman; Melissa Bolyard; Maria Khan; Carey Maslow; Milagros Sandoval; Pedro Mateu-Gelabert; Beatrice Krauss; Sevgi O Aral
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks.

Authors:  Chyvette Williams; Marlene Eisenberg; Julie Becher; Annet Davis-Vogel; Danielle Fiore; David Metzger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

10.  The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users.

Authors:  Carl Latkin; Deborah Donnell; Ting-Yuan Liu; Melissa Davey-Rothwell; David Celentano; David Metzger
Journal:  Addiction       Date:  2013-01-30       Impact factor: 6.526

View more
  7 in total

1.  Interpretation of the Individual Effect Under Treatment Spillover.

Authors:  Forrest W Crawford; Olga Morozova; Ashley L Buchanan; Donna Spiegelman
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

2.  Disseminated Effects in Agent-Based Models: A Potential Outcomes Framework and Application to Inform Preexposure Prophylaxis Coverage Levels for HIV Prevention.

Authors:  Ashley L Buchanan; S Bessey; William C Goedel; Maximilian King; Eleanor J Murray; Samuel R Friedman; M Elizabeth Halloran; Brandon D L Marshall
Journal:  Am J Epidemiol       Date:  2021-05-04       Impact factor: 4.897

3.  Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs.

Authors:  Hilary Aroke; Ashley Buchanan; Natallia Katenka; Forrest W Crawford; TingFang Lee; M Elizabeth Halloran; Carl Latkin
Journal:  AIDS Behav       Date:  2022-08-06

4.  Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data.

Authors:  Ashley Buchanan; Tianyu Sun; Jing Wu; Hilary Aroke; Jeffrey Bratberg; Josiah Rich; Stephen Kogut; Joseph Hogan
Journal:  Stat Med       Date:  2022-06-08       Impact factor: 2.497

5.  Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Authors:  Eleanor J Murray; Brandon D L Marshall; Ashley L Buchanan
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

6.  Rx for Addiction and Medication Safety (RAMS-PEER): Evaluation of an Education and Peer Program on Opioid Misuse.

Authors:  Tianyu Sun; Ashley L Buchanan; Jeffrey P Bratberg; Emily Patry; Kelly L Matson
Journal:  Prev Chronic Dis       Date:  2020-05-21       Impact factor: 2.830

7.  Complex systems models for causal inference in social epidemiology.

Authors:  Hiba N Kouser; Ruby Barnard-Mayers; Eleanor Murray
Journal:  J Epidemiol Community Health       Date:  2020-11-10       Impact factor: 3.710

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.